NEXGEL, Inc. (NXGL) Income Statement
NXGL 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsNXGL revenue and net income
Where NXGL's revenue goes
2025Each bar shows an amount and its share of revenue. NXGL kept −26.3% of revenue as net income.
NXGL profit margins
NXGL growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +31.5% | +77.3% | +76.1% | — |
| Gross profit | +64.1% | +160.2% | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
NXGL quarterly EPS vs estimates
NEXGEL beat the analyst EPS estimate in 2 of the last 8 quarters. Next report: November 10, 2026 (estimate $-4.80).
NXGL income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M | $8.7M | $4.1M | $2.0M | $1.6M | $674,000 | $717,000 | $2.2M | $2.0M | $2.2M |
| Cost of revenue | $6.9M | $5.9M | $3.7M | $1.8M | $1.5M | $965,000 | $854,000 | $1.7M | $1.8M | $2.3M |
| Gross profit | $4.5M | $2.7M | $374,000 | $256,000 | $8,000 | −$291,000 | −$137,000 | $514,000 | $147,000 | −$114,000 |
| Research & development | $2,000 | $78,000 | $103,000 | $367,000 | $31,000 | $0 | — | — | — | — |
| Sales, general & admin | $7.9M | $5.9M | $3.4M | $2.8M | $2.4M | $2.0M | $1.8M | $2.4M | — | — |
| Total operating expenses | $7.9M | $6.3M | $3.9M | $3.6M | $2.6M | $2.0M | $1.8M | $2.4M | $1.1M | $1.8M |
| Operating income | −$3.4M | −$3.6M | −$3.5M | −$3.3M | −$2.6M | −$2.3M | −$1.9M | −$1.9M | −$969,000 | −$1.9M |
| Interest expense | $34,000 | $81,000 | $15,000 | $1.3M | $2.0M | $10,000 | $1,000 | $0 | $0 | — |
| Income before taxes | −$2.9M | −$3.5M | −$3.2M | −$4.7M | −$4.3M | −$2.3M | −$1.9M | −$1.9M | −$969,000 | −$1.8M |
| Income taxes | $107,000 | −$182,000 | −$31,000 | $1.4M | $2.0M | $18,000 | −$104,860 | $160,859 | −$16,000 | −$63,000 |
| Net income | −$3.0M | −$3.3M | −$3.2M | −$4.7M | −$4.3M | −$2.3M | −$1.9M | −$1.9M | −$953,000 | −$1.8M |
| EBITDA | −$2.1M | −$2.9M | −$2.7M | −$3.1M | −$2.2M | −$2.2M | −$1.9M | −$1.6M | −$653,000 | −$1.5M |
| EPS (diluted) | −$0.42 | −$0.51 | −$0.62 | −$0.79 | −$1.01 | −$0.41 | −$0.35 | −$0.34 | −$0.17 | — |
| Gross margin | 39.5% | 31.6% | 9.1% | 12.5% | 0.5% | −43.2% | −19.1% | 23.2% | 7.4% | −5.3% |
| Operating margin | −29.3% | −40.9% | −85.0% | −163.5% | −165.7% | −335.3% | −268.3% | −85.3% | −48.6% | −86.6% |
| Net margin | −26.3% | −37.8% | −77.2% | −231.7% | −277.9% | −335.9% | −268.2% | −85.3% | −47.8% | −82.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7M | $2.6M | $2.8M | $2.9M | $2.9M | $2.8M | $3.0M | $2.9M | $1.4M | $1.3M | $1.1M | $1.2M |
| Cost of revenue | $2.6M | $1.6M | $2.0M | $1.7M | $1.6M | $1.6M | $2.3M | $1.7M | $1.0M | $1.1M | $924,000 | $877,000 |
| Gross profit | $1.1M | $1.1M | $819,000 | $1.2M | $1.3M | $1.2M | $779,000 | $1.3M | $410,000 | $160,000 | $158,000 | $344,000 |
| Research & development | $20,000 | $0 | $6,000 | $7,000 | $0 | $1,000 | $0 | $0 | $76,000 | $2,000 | $13,000 | $6,000 |
| Sales, general & admin | $3.6M | $2.0M | $2.4M | $1.9M | $1.8M | $1.9M | $1.5M | $2.0M | $1.3M | $940,000 | $1.2M | $893,000 |
| Total operating expenses | $3.6M | $2.0M | $2.0M | $2.0M | $1.9M | $2.0M | $1.6M | $2.1M | $1.5M | $1.0M | $2.3M | $956,000 |
| Operating income | −$2.5M | −$958,000 | −$1.2M | −$725,000 | −$636,000 | −$777,000 | −$841,000 | −$788,000 | −$1.1M | −$871,000 | −$1.2M | −$612,000 |
| Interest income | — | — | — | $10,000 | — | — | — | $0 | $1,000 | — | — | $1,000 |
| Interest expense | $2.2M | $42,000 | $2,000 | $10,000 | $21,000 | $21,000 | $16,000 | $20,000 | $30,000 | $15,000 | $2,000 | $3,000 |
| Income before taxes | −$3.6M | −$871,000 | −$928,000 | −$647,000 | −$640,000 | −$678,000 | −$824,000 | −$754,000 | −$979,000 | −$905,000 | −$1.2M | −$552,000 |
| Income taxes | $29,000 | $56,000 | $101,000 | $6,000 | $25,000 | $34,000 | −$850,000 | −$61,000 | −$94,000 | −$52,000 | — | −$2,000 |
| Net income | −$3.6M | −$927,000 | −$970,000 | −$653,000 | −$665,000 | −$712,000 | −$850,000 | −$693,000 | −$885,000 | −$853,000 | −$1.1M | −$550,000 |
| EBITDA | −$398,000 | −$657,000 | −$523,000 | −$535,000 | −$520,000 | −$531,000 | −$660,000 | −$550,000 | −$863,000 | −$821,000 | — | −$514,000 |
| EPS (diluted) | −$0.40 | −$0.11 | −$0.15 | −$0.08 | −$0.10 | −$0.09 | −$0.11 | −$0.11 | −$0.15 | −$0.14 | −$0.21 | −$0.11 |
| Gross margin | 30.1% | 40.0% | 29.3% | 42.4% | 43.6% | 42.3% | 25.6% | 43.6% | 28.5% | 12.6% | 14.6% | 28.2% |
| Operating margin | −68.0% | −36.2% | −43.4% | −24.7% | −22.1% | −27.7% | −27.7% | −26.8% | −73.2% | −68.8% | −112.7% | −50.1% |
| Net margin | −98.6% | −35.0% | −34.7% | −22.3% | −23.1% | −25.4% | −28.0% | −23.6% | −61.5% | −67.4% | −101.5% | −45.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NXGL's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
NXGL financial results
In fiscal year 2025 (ended December 31, 2025), NEXGEL reported revenue of $11.4 million, up 31.5% from the year before. It had a net loss of $3.0 million, a net profit margin of −26.3%. Diluted earnings per share came to −$0.42. Over five years revenue grew at an average rate of 76.1% a year.
See the NXGL stock overview for the latest quote and news, or the NXGL chart for price history and technical indicators.
NXGL income statement FAQ
What is NEXGEL's annual revenue?
NEXGEL reported total revenue of $11.4 million for fiscal year 2025, which ended on December 31, 2025. That was up 31.5% from $8.7 million the previous year.
Is NEXGEL profitable?
No. NEXGEL reported a net loss of $3.0 million in fiscal 2025, a net profit margin of −26.3%; its operating margin was −29.3%.
What is NEXGEL's gross margin?
NEXGEL's gross margin was 39.5% in fiscal 2025: for every $100 of revenue, NEXGEL kept $39 after the direct cost of its products and services.
How much does NEXGEL spend on research and development?
NEXGEL spent $0.0 million on research and development in fiscal 2025, 0.0% of revenue.
How fast is NEXGEL growing?
Revenue grew 76.1% a year on average over the last five fiscal years, from $0.7 million to $11.4 million.
What are NEXGEL's earnings per share?
NEXGEL earned $-0.42 per diluted share in fiscal 2025, compared with $-0.51 a year earlier.
When will NEXGEL report its next earnings?
NEXGEL is expected to report results for the quarter ending September 30, 2026 on November 10, 2026 before the market opens.
When does NEXGEL's fiscal year end?
NEXGEL's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 31, 2026.